Clinical Trials Directory

Trials / Completed

CompletedNCT00833352

Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
263 (actual)
Sponsor
Guidant Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This prospective, randomized, single blind, multi-centre study will examine the effect of the right ventricular (RV) lead location in patients implanted with a cardiac resynchronization defibrillator. 1. Purpose : To compare the effect of RV mid-septal (RVS) versus RV apical (RVA) lead location on left ventricular reverse remodeling in patients indicated for cardiac resynchronization therapy device (CRT-D) over a period of 6 months and to evaluate the clinical outcome of the RVS versus RVA pacing, over a period of 12 months. 2. Objectives: The primary objective is to demonstrate that there is no difference between the two groups (RVA vs. RVS) in the change of left ventricular end systolic volume (LVESV), between baseline and 6 months. The secondary objectives are to evaluate the percentage of "echo-responders" plus additional clinical and safety outcomes. This prospective, randomized, multi-centre, single-blind with 2 parallel arms, non-inferiority study will be conducted in approximately 25 study centres in Europe. The patients will be randomized in a 1:1 ratio. A maximum of 416 patients will be enrolled in this study. All eligible patients will be followed through baseline, randomisation, pre discharge, 1, 6 and 12 months post-implant. Enrolment is expected to be completed in 18 months. The total duration of the study is expected to be approximately 30 months.

Conditions

Interventions

TypeNameDescription
DEVICECRT-D TherapyImplant of a defibrillator with cardiac resynchronization therapy to detect and terminate ventricular arrhythmias and resynchronize ventricles.

Timeline

Start date
2008-11-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2009-02-02
Last updated
2014-01-30

Locations

26 sites across 2 countries: France, Spain

Source: ClinicalTrials.gov record NCT00833352. Inclusion in this directory is not an endorsement.